# Actuate Therapeutics, Inc. (ACTU) insider trading

> In the 12 months to Oct 31, 2026, one ACTU insider reported open-market sales of $1.6M across 1 filing; one president, CEO and director bought $50.0K.

Canonical: https://massive.com/quote/actu/insider-trading
Latest filing: 2026-10-30 (last 12 months; source: SEC EDGAR)
Source: Massive (https://massive.com/docs/llms.txt)

## Summary

| Measure | Value | Detail |
| --- | --- | --- |
| Open-market sales | $1.6M | 1 filing · 1 insider |
| Open-market purchases | $50.0K | 1 filing · Daniel M. Schmitt, President, CEO and Director |

## Open-market trades by insider

| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
| --- | --- | --- | --- | --- | --- | --- |
| Todd S. Thomson | Director | $1.6M | — | 1 | — | 2026-01-07 |
| Daniel M. Schmitt | President, CEO and Director | — | $50.0K | 1 | — | 2026-10-29 |

## Open-market trades by filing

2 filings in the last 12 months, newest first.

| Filed | Traded | Insider | Role | Type | Shares | Avg price | Value | Held after | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2026-10-29 | 2026-10-28 | Daniel M. Schmitt | President, CEO and Director | Purchase | 140,844 | $0.36 | $50.0K | 442,560 | — |
| 2026-01-07 | 2026-01-05 | Todd S. Thomson | Director | Sale | 280,000 | $5.80 | $1.6M | 904,795 | — |

## Other insider activity (not market trades)

- Option exercises: 2 records
- Tax withholding: 2 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

## How to read this page

- **Open-market purchase or sale**: A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- **Filing date**: Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- **Counted once**: When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.

## FAQ

### Has Actuate Therapeutics, Inc.'s CEO sold stock?

No. Daniel M. Schmitt (CEO) made no open-market sales filed as CEO in the last 12 months.

### How current is ACTU’s insider data?

These are ACTU Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

### What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

## Live data

This page joins two Massive endpoints: Form 4 filings and daily prices. The ACTU Form 4 request:

- `GET https://api.massive.com/stocks/filings/vX/form-4?tickers=ACTU&filing_date.gte=2025-10-31&sort=filing_date.desc&limit=500`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Actuate Therapeutics, Inc. (ACTU) stock price](https://massive.com/quote/actu.md)
- [Recent insider trading](https://massive.com/quote/insider-trading.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms